EMILY HERRMANN: Open Payments
NPI 1699552125 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 9 payments from 7 companies in 2025. Trend: 2023 $26 · 2024 $90 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $117 |
| Medtronic, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Optinose US, Inc. | 1 | $27 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $27 |
| Smith+Nephew, Inc. | 1 | $21 |
| ALK-Abello, Inc | 1 | $14 |
Products named: KEYTRUDA, PROPEL, NUCALA, Xhance, JOURNAVX, HALO, TIMOTHY, STANDARDIZED.
Industry payments across TX — which companies pay providers there.
